Clinical Research Directory
Browse clinical research sites, groups, and studies.
Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)
Sponsor: Shanghai Chest Hospital
Summary
This is an investigator-initiated, single-arm, exploratory clinical study.The study population consisted of non-operative Locally Advanced Esophageal Cancer . The purpose of this study was to evaluate the efficacy and safety of Concurrent Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Patients With Locally-advanced Esophageal Squamous Cell Cancer.
Official title: A Phase 2 Trial of Concurrent Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Patients With Locally-advanced Esophageal Squamous Cell Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2022-11-02
Completion Date
2026-10
Last Updated
2026-02-02
Healthy Volunteers
No
Interventions
chemotherapy combined with PD-1 inhibitors
Induction chemotherapy combined with PD-1 inhibitors followed with standard concurrent chemoradiotherapy
Locations (1)
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China